The First Generic Biological Enoxaparin Sodium in Egypt & Africa
We proudly announce the launch of Exapine, the first generic biological Enoxaparin Sodium registered in Egypt and Africa.
Exapine is manufactured on a dedicated sterile prefilled syringe production line, ensuring the highest standards of quality and safety. All batches are approved and released by the Egyptian Drug Authority (EDA) and the National Organization for Research and Control of Biologicals (NORCB) in full compliance with national regulatory requirements.
Exapine is a life-saving anticoagulant indicated for:
- Prevention and treatment of venous thromboembolism (VTE)
- Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
- Acute coronary syndromes including NSTEMI and STEMI
- Prevention of clot formation during hemodialysis
The importance of Exapine increased significantly during the COVID-19 pandemic, highlighting its critical role in thrombosis management.
Exapine is supplied to the Egyptian market at an affordable price, supporting wider patient access to high-quality biological therapy.